Pricing Log in Create free account

Karyopharm Therapeutics Inc. (KPTI) vs Lakewood-Amedex Biotherapeutics Inc. (LABT)

Karyopharm Therapeutics Inc. and Lakewood-Amedex Biotherapeutics Inc. are both Biotechnology companies. Karyopharm Therapeutics Inc. and Lakewood-Amedex Biotherapeutics Inc. are of similar size ($1.4M and $1.3M). Lakewood-Amedex Biotherapeutics Inc. has the higher net margin (0.00% vs −153.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Lakewood-Amedex Biotherapeutics Inc. leads on 7 and Karyopharm Therapeutics Inc. on 4.

Valuation

Metric KPTI LABT Biotechnology median
P/E n/m n/m 10.60
P/S 0.01 n/m 9.40
P/B n/m 0.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.71 0.66
EV/Sales 1.27 n/m 9.02
Earnings yield (25,680.00%) (2,135.14%) (32.88%)
Free cash flow yield (4,526.16%) (934.12%) (23.13%)

Profitability

Metric KPTI LABT Biotechnology median
Gross margin 95.89% — 68.51%
Operating margin (56.17%) 0.00% 0.00%
Net margin (153.28%) 0.00% 0.00%
Free cash flow margin (44.57%) 0.00% 0.00%
Return on equity 78.98% 0.00% (51.96%)
Return on assets (207.90%) (302.50%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KPTI LABT Biotechnology median
Revenue growth (TTM) 6.81% — 6.76%
EPS growth (last fiscal year) (28.07%) 15.32% 29.88%
Revenue growth, 5-year CAGR 6.21% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KPTI LABT Biotechnology median
Debt to equity (0.76) 0.00 0.00
Current ratio 0.79 7.70 4.97
Net debt to EBITDA (2.03) 0.06 1.01

Dividend

Metric KPTI LABT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPTI LABT Biotechnology median
Market cap 1.36m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack